The 5 key players our Neglected Tropical Disease Drugs report profiles, and other companies free public records show in this market.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Merck & Co., Inc. |
merck.com (opens in a new tab) | 1,320 reports |
| 2 | GSK PLC |
gsk.com (opens in a new tab) | 1,254 reports |
| 3 | Sanofi |
sanofi.com (opens in a new tab) | 1,386 reports |
| 4 | Novartis AG |
novartis.com (opens in a new tab) | 1,551 reports |
| 5 | DNDi | — | 33 reports |
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Source: WHO Prequalification, Vaccines, tests and medicines on the WHO prequalified lists that match this market. Retrieved 13 Nov 2026.
One report for each place. Each tile opens that place's report.
Compare all 33 places for Neglected Tropical Disease Drugs, with active trials
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.